ArriVent BioPharma Inc (AVBP)
NASDAQ
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
| Quarter End | Dec 2023 | Mar 2024 |
|---|---|---|
| USD ($) | USD ($) | |
| Total Revenue | 0 | 0 |
| Operating Income | -23.12M | -20.67M |
| Pre Tax Income | -21.19M | -17.42M |
| Net Income | -21.19M | -17.42M |
| Preferred Dividends | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 |
| EBIT | -23.12M | -20.67M |
| EBITDA | -23.12M | -20.67M |
| Year End December 30 2023 | 2022 | 2023 |
|---|---|---|
| USD ($) | USD ($) | |
| Total Revenue | 0 | 0 |
| Operating Income | -36.91M | -74.59M |
| Pre Tax Income | -36.91M | -69.33M |
| Net Income | -36.91M | -69.33M |
| Preferred Dividends | 0 | 0 |
| Basic Earnings Per Share (EPS) | -0.125 | -0.231 |
| EBIT | -36.91M | -74.59M |
| EBITDA | -36.91M | -74.59M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
